Nepmucin/CLM-9, an Ig domain-containing sialomucin in vascular endothelial cells, promotes lymphocyte transendothelial migration in vitro

Nepmucin/CLM-9 is an Ig domain-containing sialomucin expressed in vascular endothelial cells. Here we show that, like CD31, nepmucin was localized to interendothelial contacts and to vesicle-like structures along the cell border and underwent intracellular recycling. Functional analyses showed that...

Full description

Saved in:
Bibliographic Details
Published inFEBS letters Vol. 582; no. 20; pp. 3018 - 3024
Main Authors Jin, Soojung, Umemoto, Eiji, Tanaka, Toshiyuki, Shimomura, Yoshimitsu, Tohya, Kazuo, Kunizawa, Keiji, Yang, Bo-Gie, Jang, Myoung Ho, Hirata, Takako, Miyasaka, Masayuki
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 03.09.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nepmucin/CLM-9 is an Ig domain-containing sialomucin expressed in vascular endothelial cells. Here we show that, like CD31, nepmucin was localized to interendothelial contacts and to vesicle-like structures along the cell border and underwent intracellular recycling. Functional analyses showed that nepmucin mediated homotypic and heterotypic cell adhesion via its Ig domain. Nepmucin-expressing endothelial cells showed enhanced lymphocyte transendothelial migration (TEM), which was abrogated by anti-nepmucin mAbs that block either homophilic or heterophilic binding. Notably, the mAbs that inhibited homophilic binding blocked TEM without affecting lymphocyte adhesion. These results suggest that endothelial nepmucin promotes lymphocyte TEM using multiple adhesion pathways.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-5793
1873-3468
DOI:10.1016/j.febslet.2008.07.041